Elucidating the potential of EGFR mutated NSCLC and identifying its multitargeted inhibitors

Abstract Lung cancer is the leading cause of cancer-related fatalities globally, accounting for the highest mortality rate among both men and women. Mutations in the epidermal growth factor receptor (EGFR) gene are frequently found in non-small cell lung cancer (NSCLC). Since curcumin and CB[2]UN su...

Full description

Saved in:
Bibliographic Details
Main Authors: Anakha D. Rajeeve, Ramasamy Yamuna, P. K. Krishnan Namboori
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-83868-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571784784773120
author Anakha D. Rajeeve
Ramasamy Yamuna
P. K. Krishnan Namboori
author_facet Anakha D. Rajeeve
Ramasamy Yamuna
P. K. Krishnan Namboori
author_sort Anakha D. Rajeeve
collection DOAJ
description Abstract Lung cancer is the leading cause of cancer-related fatalities globally, accounting for the highest mortality rate among both men and women. Mutations in the epidermal growth factor receptor (EGFR) gene are frequently found in non-small cell lung cancer (NSCLC). Since curcumin and CB[2]UN support various medicinal applications in drug delivery and design, we investigated the effect of curcumin and CB[2]UN-based drugs in controlling EGFR-mutant NSCLC through a dodecagonal computational approach. Molecular docking studies revealed that the ligands curcumin (-6.9 kcal/mol) and CB[2]UN (-8.1 kcal/mol) bound more strongly to the EGFR-mutant NSCLC proteins with 2ITX and 2ITV, respectively. Molecular dynamics simulation (50 ns) investigation of protein-ligand complexes using RMSD, RMSF, Rg, and SASA indicated that curcumin and CB[2]UN with EGFR-mutant proteins are kinetically stable. In addition, MMPBSA/MMGBSA analysis confirmed the thermodynamic stability of each curcumin and CB[2]UN protein-ligand complex. Finally, KDeep absolute binding affinity calculations show energies of -6.13 kcal/mol and − 5.26 kcal/mol for 2ITX-CUR and 2ITV-CB[2]UN protein-ligand complexes, respectively. Thus, our dodecagonal strategy reveals that 2ITX-CUR and 2ITV-CB[2]UN are more likely to form protein-ligand complexes with more significant binding affinities and excellent stability throughout the 50 ns simulation time.
format Article
id doaj-art-49e5dae9a3ac446192525f12eb9f910e
institution Kabale University
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-49e5dae9a3ac446192525f12eb9f910e2025-02-02T12:17:06ZengNature PortfolioScientific Reports2045-23222025-01-0115112210.1038/s41598-024-83868-5Elucidating the potential of EGFR mutated NSCLC and identifying its multitargeted inhibitorsAnakha D. Rajeeve0Ramasamy Yamuna1P. K. Krishnan Namboori2Department of Chemistry, Amrita School of Physical Sciences Coimbatore, Amrita Vishwa VidyapeethamDepartment of Chemistry, Amrita School of Physical Sciences Coimbatore, Amrita Vishwa VidyapeethamAmrita School of Artificial Intelligences, Coimbatore, Amrita Vishwa VidyapeethamAbstract Lung cancer is the leading cause of cancer-related fatalities globally, accounting for the highest mortality rate among both men and women. Mutations in the epidermal growth factor receptor (EGFR) gene are frequently found in non-small cell lung cancer (NSCLC). Since curcumin and CB[2]UN support various medicinal applications in drug delivery and design, we investigated the effect of curcumin and CB[2]UN-based drugs in controlling EGFR-mutant NSCLC through a dodecagonal computational approach. Molecular docking studies revealed that the ligands curcumin (-6.9 kcal/mol) and CB[2]UN (-8.1 kcal/mol) bound more strongly to the EGFR-mutant NSCLC proteins with 2ITX and 2ITV, respectively. Molecular dynamics simulation (50 ns) investigation of protein-ligand complexes using RMSD, RMSF, Rg, and SASA indicated that curcumin and CB[2]UN with EGFR-mutant proteins are kinetically stable. In addition, MMPBSA/MMGBSA analysis confirmed the thermodynamic stability of each curcumin and CB[2]UN protein-ligand complex. Finally, KDeep absolute binding affinity calculations show energies of -6.13 kcal/mol and − 5.26 kcal/mol for 2ITX-CUR and 2ITV-CB[2]UN protein-ligand complexes, respectively. Thus, our dodecagonal strategy reveals that 2ITX-CUR and 2ITV-CB[2]UN are more likely to form protein-ligand complexes with more significant binding affinities and excellent stability throughout the 50 ns simulation time.https://doi.org/10.1038/s41598-024-83868-5Lung cancerEGFRCucurbiturilDodecagonal strategyMultitargeted inhibitorsMolecular dynamics simulation
spellingShingle Anakha D. Rajeeve
Ramasamy Yamuna
P. K. Krishnan Namboori
Elucidating the potential of EGFR mutated NSCLC and identifying its multitargeted inhibitors
Scientific Reports
Lung cancer
EGFR
Cucurbituril
Dodecagonal strategy
Multitargeted inhibitors
Molecular dynamics simulation
title Elucidating the potential of EGFR mutated NSCLC and identifying its multitargeted inhibitors
title_full Elucidating the potential of EGFR mutated NSCLC and identifying its multitargeted inhibitors
title_fullStr Elucidating the potential of EGFR mutated NSCLC and identifying its multitargeted inhibitors
title_full_unstemmed Elucidating the potential of EGFR mutated NSCLC and identifying its multitargeted inhibitors
title_short Elucidating the potential of EGFR mutated NSCLC and identifying its multitargeted inhibitors
title_sort elucidating the potential of egfr mutated nsclc and identifying its multitargeted inhibitors
topic Lung cancer
EGFR
Cucurbituril
Dodecagonal strategy
Multitargeted inhibitors
Molecular dynamics simulation
url https://doi.org/10.1038/s41598-024-83868-5
work_keys_str_mv AT anakhadrajeeve elucidatingthepotentialofegfrmutatednsclcandidentifyingitsmultitargetedinhibitors
AT ramasamyyamuna elucidatingthepotentialofegfrmutatednsclcandidentifyingitsmultitargetedinhibitors
AT pkkrishnannamboori elucidatingthepotentialofegfrmutatednsclcandidentifyingitsmultitargetedinhibitors